Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Akari Therapeutics Plc | Director | Ordinary Shares, par value $0.0001 per share | 20M | Jan 1, 2024 | Direct | ||
Akari Therapeutics Plc | Director | Stock Option (Right to Buy) | 5M | Jun 28, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
AKTX | Akari Therapeutics Plc | Jun 28, 2024 | 1 | $0 | 4 | Jul 2, 2024 | Director |
AKTX | Akari Therapeutics Plc | Jan 1, 2024 | 0 | $0 | 3 | Jan 2, 2024 | Director |